Endocyte (ECYT) Tops Q1 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to Endocyte (ECYT) Tops Q1 EPS by 1c

Endocyte Reports First Quarter 2016 Financial Results

May 4, 2016 8:03 AM EDT

- Data from Phase 1 Dose Escalation Studies of EC1456 and EC1169 to be Presented at ASCO -

- Expansion Phase of Trials in Targeted Patients Expected to Yield Efficacy Data in 2016 -

- Promising Preclinical Data Demonstrates Unique SMDC Applications in Immuno-Oncology -

      - Conference Call Today at 8:30 a.m. EDT

WEST LAFAYETTE, Ind., May 04, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ: ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for... More